STOCK TITAN

AMETEK Announces Record Fourth Quarter and Full Year Results

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Very Positive)
Tags
Rhea-AI Summary
AMETEK, Inc. (AME) announced its financial results for Q4 2023, reporting a record $1.73 billion in sales, a 6.5% increase from Q4 2022. Operating income increased by 12% to a record $445.0 million, with operating margins at 25.7%. GAAP earnings per diluted share were $1.48, while adjusted earnings were a record $1.68 per share. Full-year sales were a record $6.60 billion, up 7% over 2022, with adjusted earnings at $6.38 per share, a 12% increase over 2022. The Electronic Instruments Group (EIG) and Electromechanical Group (EMG) both delivered strong performances, with EIG sales reaching a record $1.24 billion and EMG sales at $494.7 million in Q4 2023. For 2024, AMETEK expects overall sales to be up low double digits, with adjusted earnings per diluted share in the range of $6.70 to $6.85.
Positive
  • None.
Negative
  • None.

Insights

AMETEK's record sales and earnings for Q4 2023 and the full year reflect a robust financial health and operational efficiency. The 6.5% year-over-year sales growth, coupled with a 12% increase in operating income and a significant 40% increase in operating cash flow, indicate a strong demand for the company's products and efficient cost management. The operating margin expansion from 25.7% in Q4 to 25.9% for the full year suggests improved profitability, likely due to economies of scale and possibly effective integration of recent acquisitions.

Investors should note the adjusted earnings per share (EPS) of $1.68, which excludes non-cash acquisition-related amortization, providing a clearer picture of the company's operational performance. This adjustment is crucial for evaluating the true earnings potential of AMETEK's core business. Furthermore, the company's guidance for 2024, projecting low double-digit sales growth and a 5% to 7% increase in adjusted EPS, reflects management's confidence in sustained growth, which could be a positive signal for investors looking at long-term value creation.

The Electronic Instruments Group (EIG) and Electromechanical Group (EMG) both reported strong sales and operating income growth, with EIG in particular showing a significant 250 basis point increase in operating margins. This performance underscores the competitive advantage and market leadership of AMETEK's specialized instrument segments. It's indicative of strong organic growth and successful integration of strategic acquisitions like Paragon Medical, enhancing the company's market position.

AMETEK's diversified market exposure and record backlog suggest resilience against economic headwinds and potential for sustained revenue streams. The company's focus on aerospace and defense within the EMG segment is particularly noteworthy as these industries often provide stable long-term contracts that can lead to predictable and consistent revenue.

The financial results and forward-looking statements from AMETEK provide a positive outlook for investors, especially in terms of the company's growth model and strategic capital deployment. The record financial performance, combined with a strong balance sheet and robust cash flows, suggests that AMETEK is well-equipped to continue its growth trajectory through both organic initiatives and further acquisitions.

Investors should consider the company's ability to drive long-term value creation through a disciplined capital allocation strategy that focuses on high-margin, niche markets. However, they should also be aware of the inherent risks associated with acquisitions, such as integration challenges and potential for goodwill impairment, which could affect future earnings.

BERWYN, Pa., Feb. 6, 2024 /PRNewswire/ -- AMETEK, Inc. (NYSE: AME) today announced its financial results for the fourth quarter ended December 31, 2023.

AMETEK's fourth quarter 2023 sales were a record $1.73 billion, a 6.5% increase over the fourth quarter of 2022. Operating income increased 12% to a record $445.0 million and operating margins were 25.7%, up 120 basis points from the fourth quarter of 2022. Operating cash flow in the quarter was a record $540.7 million, up 40% versus the prior year.

On a GAAP basis, fourth quarter earnings per diluted share were $1.48. Adjusted earnings in the quarter were a record $1.68 per diluted share, up 11% from the fourth quarter of 2022. Adjusted earnings adds back non-cash, after-tax, acquisition-related intangible amortization of $0.20 per diluted share. A reconciliation of reported GAAP results to adjusted results is included in the financial tables accompanying this release and on the AMETEK website.

"AMETEK's fourth quarter and full year performance was exceptional," noted David A. Zapico, AMETEK Chairman and Chief Executive Officer. "Contributions from organic sales growth and recent acquisitions, along with tremendous operating performance, led to robust margin expansion, record earnings and impressive cash flow growth in the quarter and the full year. We also continued to strengthen our portfolio in 2023, deploying approximately $2.25 billion in capital on acquisitions, including our most recent acquisition, Paragon Medical." 

For the full year, AMETEK's sales were a record $6.60 billion, an increase of 7% over 2022. Operating income was $1.71 billion, up 14% versus the prior year, and operating income margins were 25.9%, expanding 150 basis points over last year's margins.   

On a GAAP basis, full year 2023 earnings were $5.67 per diluted share. Full year adjusted earnings were $6.38 per share, an increase of 12% over 2022's comparable adjusted earnings of $5.68 per share. AMETEK established annual records for sales, operating income, operating margin, and earnings per share.

Electronic Instruments Group (EIG)
EIG sales in the fourth quarter were a record $1.24 billion, up 7% from the same quarter in 2022. EIG's operating income in the quarter increased 17% to a record $359.0 million and operating income margins were 29.0%, an increase of 250 basis points compared to the fourth quarter of 2022.

"EIG delivered outstanding results in the fourth quarter," commented Mr. Zapico. "The sales growth was driven by continued solid organic growth and contributions from recent acquisitions. Our EIG businesses drove exceptional margin expansion, a testament to the quality of our businesses and our team's focus on driving continuous operational improvements."

Electromechanical Group (EMG)
EMG sales in the fourth quarter were $494.7 million, up 6% from the fourth quarter of 2022. EMG's fourth quarter operating income was $112.3 million, while operating income margins were 22.7% in the quarter. 

"EMG also delivered a strong fourth quarter performance with continued excellent growth across our aerospace and defense businesses and solid core margin expansion in the quarter," stated Mr. Zapico.

2024 Outlook
"AMETEK's businesses delivered exceptional results in the fourth quarter and for the full year. The strength of the AMETEK Growth Model, alongside the outstanding contributions of our colleagues, allowed us to deliver strong, high-quality growth. The strength of our niche businesses, diverse market exposures, record backlog and robust operating capabilities position us for sustained growth. With a flexible balance sheet and strong cash flows, we are well positioned to invest in our organic growth initiatives and pursue strategic acquisitions to drive long-term value creation," noted Mr. Zapico.

"For 2024, we expect overall sales to be up low double digits on a percentage basis compared to 2023. Adjusted earnings per diluted share are expected to be in the range of $6.70 to $6.85, an increase of 5% to 7% over the comparable basis for 2023," he added.

"For the first quarter of 2024, overall sales are expected to be up low double digits on a percentage basis compared to the same period last year. Adjusted earnings in the quarter are anticipated to be in the range of $1.56 to $1.60 per share, up 5% to 7% compared to the first quarter of 2023," concluded Mr. Zapico.

Conference Call
AMETEK will webcast its fourth quarter 2023 investor conference call on Tuesday, February 6, 2024, beginning at 8:30 AM ET. The live audio webcast will be available and later archived in the Investors section of www.ametek.com.

About AMETEK
AMETEK (NYSE: AME) is a leading global provider of industrial technology solutions serving a diverse set of attractive niche markets with annualized sales over $7.0 billion. The AMETEK Growth Model integrates the Four Growth Strategies - Operational Excellence, New Product Development, Global and Market Expansion, and Strategic Acquisitions - with a disciplined focus on cash generation and capital deployment. AMETEK's objective is double-digit percentage growth in earnings per share over the business cycle and a superior return on total capital. Founded in 1930, AMETEK has been listed on the NYSE for over 90 years and is a component of the S&P 500. For more information, visit www.ametek.com.

Forward-looking Information
Statements in this news release relating to future events, such as AMETEK's expected business and financial performance are "forward-looking statements." Forward-looking statements are subject to various factors and uncertainties that may cause actual results to differ significantly from expectations. These factors and uncertainties include risks related to AMETEK's ability to consummate and successfully integrate future acquisitions; risks with international sales and operations, including supply chain disruptions; AMETEK's ability to successfully develop new products, open new facilities or transfer product lines; the price and availability of raw materials; compliance with government regulations, including environmental regulations; changes in the competitive environment or the effects of competition in our markets; the ability to maintain adequate liquidity and financing sources; and general economic conditions affecting the industries we serve. A detailed discussion of these and other factors that may affect our future results is contained in AMETEK's filings with the U.S. Securities and Exchange Commission, including its most recent reports on Forms 10-K, 10-Q and 8-K. AMETEK disclaims any intention or obligation to update or revise any forward-looking statements.

Contact:
Kevin Coleman
Vice President, Investor Relations and Treasurer
kevin.coleman@ametek.com
Phone: 610.889.5247

 

AMETEK, Inc.

Consolidated Statement of Income

(In thousands, except per share amounts)

(Unaudited)






Three Months Ended
December 31,


Year Ended
December 31,


2023


2022


2023


2022

Net sales

$      1,730,885


$      1,625,667


$      6,596,950


$      6,150,530









Cost of sales

1,115,850


1,063,657


4,212,485


4,005,261

Selling, general and administrative

170,043


163,920


677,006


644,577

     Total operating expenses

1,285,893


1,227,577


4,889,491


4,649,838

Operating income

444,992


398,090


1,707,459


1,500,692

Interest expense

(24,117)


(23,021)


(81,795)


(83,186)

Other (expense) income, net

(3,939)


3,435


(19,252)


11,186

Income before income taxes

416,936


378,504


1,606,412


1,428,692

Provision for income taxes

74,072


71,422


293,224


269,150

Net income

$         342,864


$         307,082


$      1,313,188


$      1,159,542









Diluted earnings per share

$               1.48


$               1.33


$               5.67


$               5.01

Basic earnings per share

$               1.49


$               1.34


$               5.70


$               5.04









Weighted average common shares outstanding:








     Diluted shares

231,794


231,118


231,509


231,536

     Basic shares

230,782


229,750


230,519


230,208









Dividends per share

$               0.25


$               0.22


$               1.00


$               0.88

 

AMETEK, Inc.

Information by Business Segment

(In thousands)

(Unaudited)






Three Months Ended
December 31,


Year Ended
December 31,


2023


2022


2023


2022

Net sales:








Electronic Instruments

$      1,236,227


$      1,159,222


$      4,624,250


$      4,229,353

Electromechanical

494,658


466,445


1,972,700


1,921,177

Consolidated net sales

$      1,730,885


$      1,625,667


$      6,596,950


$      6,150,530









Operating income:








Segment operating income:








Electronic Instruments

$         358,992


$         307,126


$      1,310,962


$      1,089,729

Electromechanical

112,316


114,546


496,569


503,593

Total segment operating income

471,308


421,672


1,807,531


1,593,322

Corporate administrative expenses

(26,316)


(23,582)


(100,072)


(92,630)

Consolidated operating income

$         444,992


$         398,090


$      1,707,459


$      1,500,692

 

AMETEK, Inc.

Condensed Consolidated Balance Sheet

(In thousands)






December 31,


December 31,


2023


2022


(Unaudited)



ASSETS




Current assets:




     Cash and cash equivalents

$         409,804


$         345,386

     Receivables, net

1,012,932


919,335

     Inventories, net

1,132,471


1,044,284

     Other current assets

269,461


219,053

          Total current assets

2,824,668


2,528,058





Property, plant and equipment, net

891,293


635,641

Right of use asset, net

229,723


170,295

Goodwill

6,447,629


5,372,562

Other intangibles, investments and other assets

4,630,220


3,724,564

          Total assets

$    15,023,533


$    12,431,120





LIABILITIES AND STOCKHOLDERS' EQUITY




Current liabilities:




     Short-term borrowings and current portion of long-term debt, net

$      1,417,915


$         226,079

     Accounts payable and accruals

1,464,658


1,338,123

          Total current liabilities

2,882,573


1,564,202





Long-term debt, net

1,895,432


2,158,928

Deferred income taxes and other long-term liabilities

1,515,337


1,231,478

Stockholders' equity

8,730,191


7,476,512

          Total liabilities and stockholders' equity

$    15,023,533


$    12,431,120

 

 

AMETEK, Inc.

Reconciliations of GAAP to Non-GAAP Financial Measures

(Unaudited)








Diluted Earnings Per Share


Three Months Ended


Year Ended


December 31,


December 31,


2023


2022


2023


2022









Diluted earnings per share (GAAP)

$               1.48


$               1.33


$               5.67


$               5.01

Pretax amortization of acquisition-related intangible assets

0.26


0.25


0.93


0.89

Income tax benefit on amortization of acquisition-related intangible assets

(0.06)


(0.06)


(0.22)


(0.22)

Adjusted Diluted earnings per share (Non-GAAP)

$               1.68


$               1.52


$               6.38


$               5.68






Forecasted Diluted Earnings Per Share


Three Months Ended


Year Ended


March 31, 2024


December 31, 2024


Low


High


Low


High









Diluted earnings per share (GAAP)

$             1.35


$             1.39


$             5.88


$             6.03

Pretax amortization of acquisition-related intangible assets

0.27


0.27


1.08


1.08

Income tax benefit on amortization of acquisition-related intangible assets

(0.06)


(0.06)


(0.26)


(0.26)

Adjusted Diluted earnings per share (Non-GAAP)

$             1.56


$             1.60


$             6.70


$             6.85

 

Use of Non-GAAP Financial Information

The Company supplements its consolidated financial statements presented on a U.S. generally accepted accounting principles ("GAAP") basis with certain non-GAAP financial information to provide investors with greater insight, increased transparency and allow for a more comprehensive understanding of the information used by management in its financial and operational decision-making.  Reconciliation of non-GAAP measures to their most directly comparable GAAP measures are included in the accompanying financial tables. These non-GAAP financial measures should be considered in addition to, and not as a replacement for, or superior to, the comparable GAAP measure, and may not be comparable to similarly titled measures reported by other companies.

The Company believes that these measures provide useful information to investors by reflecting additional ways of viewing AMETEK's operations that, when reconciled to the comparable GAAP measure, helps our investors to better understand the long-term profitability trends of our business, and facilitates easier comparisons of our profitability to prior and future periods and to our peers.

Cision View original content:https://www.prnewswire.com/news-releases/ametek-announces-record-fourth-quarter-and-full-year-results-302053798.html

SOURCE AMETEK, Inc.

FAQ

What were AMETEK's sales in Q4 2023?

AMETEK reported a record $1.73 billion in sales in Q4 2023, a 6.5% increase from Q4 2022.

What was the operating income in Q4 2023?

AMETEK's operating income in Q4 2023 increased by 12% to a record $445.0 million.

What were the adjusted earnings per diluted share in Q4 2023?

AMETEK's adjusted earnings in Q4 2023 were a record $1.68 per diluted share, up 11% from Q4 2022.

What were AMETEK's full-year sales in 2023?

AMETEK's full-year sales were a record $6.60 billion, an increase of 7% over 2022.

What are AMETEK's expectations for 2024 sales?

AMETEK expects overall sales to be up low double digits in 2024.

Ametek, Inc.

NYSE:AME

AME Rankings

AME Latest News

AME Stock Data

41.96B
230.21M
0.41%
88.2%
1.15%
Specialty Industrial Machinery
Industrial Instruments for Measurement, Display, and Control
Link
United States of America
BERWYN